Next Article in Journal
The Effect of Nut Oil Cakes on Selected Properties of Enriched Wheat Bread and Their Changes During Storage
Previous Article in Journal
Paradigm Shift in Bioenergy: Addressing the System of Biomass Wastage and Environmental Pollution with Biomaterial Valorisation into Biochar
Previous Article in Special Issue
The Effect of Selected Winter Wheat Cultivars and the Growing Season on the Antioxidant Activity, Polyphenol Profile, and Organoleptic Assessment of Beers Produced from Them
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antidiabetic and Anti-Inflammatory Potential of Sorbus aucuparia Fruits (Rowanberries) from Romania

1
Centre of Bioanalysis, National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, 060031 Bucharest, Romania
2
Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, 060031 Bucharest, Romania
*
Authors to whom correspondence should be addressed.
Appl. Sci. 2025, 15(23), 12585; https://doi.org/10.3390/app152312585 (registering DOI)
Submission received: 16 October 2025 / Revised: 25 November 2025 / Accepted: 25 November 2025 / Published: 27 November 2025

Abstract

This study aimed to obtain extracts concentrated in polyphenolic compounds from Sorbus aucuparia fruits and evaluate their antioxidant, antidiabetic, anti-inflammatory, and cytotoxic potential. Two modern extraction methods were used, ultrasound-assisted extraction (UAE) and accelerated solvent extraction (ASE), to obtain hydroalcoholic extracts (50% EtOH v/v, 15% mass), then the extracts were purified and concentrated by membrane technologies and analyzed spectrophotometrically and chromatographically. HPLC analysis revealed the predominant polyphenolic compounds as chlorogenic acid (526.08 ± 23.35 µg/mL), rutin (36.07 ± 1.23 µg/mL), and caffeic acid (34.41 ± 1.21 µg/mL). The antidiabetic and anti-inflammatory potential of the extracts was analyzed spectrophotometrically by testing their capacity to inhibit α-amylase and α-glucosidase, and, respectively, hyaluronidase (HYA) and lipoxygenase (LOX). The cytotoxic potential of the extracts was tested on the mouse fibroblast NCTC clone L929 cell line. The concentrated ASE extracts showed a pronounced inhibitory activity on the tested enzymes: IC50α-glucosidase was 13.50 ± 0.96 µg/mL, (IC50acarbose was 20.19 ± 1.67 µg/mL), IC50α-amylase was 23.74 ± 1.32 µg/mL (IC50acarbose was 22.65 ± 1.27 µg/mL), and IC50LOX was 24.30 ± 1.54 µg/mL (IC50ibuprofen was 26.91 ± 1.27 µg/mL), IC50HYA was 43.04 ± 2.19 µg/mL (IC50ibuprofen was 51.54 ± 3.67 µg/mL). Also, the concentrated UAE extracts presented inhibitory activity superior to or close to that of the standard used, as follows: IC50HYA was 48.49 ± 3.15 µg/mL (IC50ibuprofen was 51.54 ± 3.67 µg/mL) and IC50α-glucosidase was 21.53 ± 1.25 µg/mL (IC50acarbose was 20.19 ± 1.67 µg/mL). The results obtained showed that Sorbus aucuparia fruits could be used in products for diabetes and inflammatory diseases.

1. Introduction

Recent years have seen a marked increase in the focus on bioactive compounds of natural origin. This trend is driven, in part, by the fact that around 80% of the global population relies on medicinal plants for various health concerns, with over 40% of currently available synthetic medications deriving from botanical or microbial sources [1].
Natural bioactive compounds have potential applications in the pharmaceutical, cosmetic, and food industries [2,3], as well as in the field of nutraceuticals and dietary supplements, a growing area of interest [4]. Natural compounds have the potential to be utilized in food products, with the aim of enhancing their quality and nutritional value. They can be incorporated into food additives, with the objective of extending the shelf life of products [2] or can be used in food supplements and various other formulations [5,6].
Natural bioactive compounds offer significant benefits due to their anti-inflammatory, anti-aging, antioxidant, and anticancer properties [7], as well as their immunostimulatory effects [8], cardiovascular protection [9], and other advantages [10].
Sorbus aucuparia (the Rosaceae family), also known as European rowanberry or mountain-ash, is recognized and used in Europe and Asia in folk medicine as a remedy for various ailments, including respiratory, gastrointestinal, cancer [11,12], hypertension [13], gout, rheumatism, and respiratory infections [14], as well as diuretic, anti-inflammatory, vasorelaxant, and anti-diabetic properties, and also as a source of vitamin C [15].
Preparations from rowanberry fruits have been used to treat hemorrhoids and gout, as well as for wound cleansing in Lithuania [16]. Tea prepared from the bark of S. aucuparia has been successfully used to treat cancer [17]. Leaf preparations have been used to treat cancer, gastrointestinal diseases, and prostate diseases [18]. The flowers have been used as a diuretic and anti-inflammatory agent [19].
Phytochemical studies of the plant have described the presence of polyphenolic compounds including flavonoids, flavanols, quercetin, and kaempferol derivatives [20,21], as well as triterpenes, sterols, coumarins, carboxylic acids, and cyanogenic glycosides [11], and carotenoids, organic acids, microelements, and ascorbic acid [22,23].
Numerous studies have demonstrated that berries are a rich source of polyphenolic compounds that exhibit a wide range of biological properties, including anti-diabetic, anti-inflammatory, and anticancer effects [24,25]. These compounds also have important antioxidant properties, as they can capture and neutralize free radicals, chelate heavy metals, and inhibit pro-inflammatory enzymes [26,27]. They are therefore considered promising agents for protecting against, and even treating, pathologies mediated by oxidative stress [23].
Reactive oxygen species (ROS) generate oxidative stress, which causes the denaturation of macromolecules in the body, including nucleic acids, lipids, and proteins. Oxidative stress has been identified as a contributing factor in a number of chronic diseases, including cancer, diabetes, neurodegenerative diseases, and cardiovascular diseases [28], and is also involved in the inflammatory process [29].
The beneficial effects of berry polyphenols on the regulation of type 2 diabetes have attracted increasing attention recently [30]. Studies have primarily focused on red cranberries and blueberries and, to a lesser extent, on Sorbus fruits and have shown antidiabetic activity in vitro and in vivo as well as in clinical studies [31,32].
Berry polyphenols act in insulin-independent type 2 diabetes by inhibiting digestive enzymes (α-amylase and α-glucosidase), which are involved in carbohydrate hydrolysis, as well as by inhibiting glucose absorption in the gastrointestinal tract [32]. Drugs such as acarbose, miglitol, and voglibose are commonly used as inhibitors of these enzymes; however, they often cause unpleasant side effects, including discomfort, diarrhea, and flatulence [33]. Therefore, finding new enzyme inhibitors is desirable, and natural compounds are a viable alternative.
The body’s first response to external stimuli that cause trauma is the inflammatory process. This can lead to various diseases, including allergies, cardiovascular diseases, autoimmune diseases, and even cancer [34]. Lipoxygenase and hyaluronidase are enzymes involved in the inflammatory process, among others, and inhibitors of their activity are the basis of treatments for allergies and inflammatory diseases [35,36].
Lipoxygenase (LOX) is involved in the catalysis of a fatty acid, producing metabolites that are implicated in various diseases, such as type 1 diabetes, type 2 diabetes, neurodegenerative diseases, and kidney diseases [37], and catalyzes arachidonic acid, generating metabolites such as leukotrienes, which are released by leukocytes and mast cells [38]. Leukotrienes are involved in the occurrence of the inflammatory process [39]. Inhibitors on the market, e.g., zileuton, have limited use due to unwanted side effects [40]; thus, it is therefore necessary to find new, safe lipoxygenase inhibitors with high clinical efficacy.
Hyaluronidase (HYA) acts on hyaluronic acid (HA), a component of the extracellular matrix in soft connective tissues, including the skin, synovial fluid, and umbilical cord [41]. It has been demonstrated that HYA is implicated in a variety of physiological and pathological processes such as cell migration, embryogenesis, wound healing, malignant transformation [42,43], and inflammation [36]. Excessive degradation of HA by HYA, along with ROS, causes a reduction in both the amount and quantity of HA, as observed in rheumatoid arthritis [39]. Biologically active plant compounds, including flavonoids, tannins, and curcumin, act as hyaluronidase inhibitors [41]. These compounds have the potential to serve as anti-inflammatory and antiallergic agents, as well as being utilized in the complementary therapy of arthritis [41,44,45].
Ultrasound-assisted extraction (UAE) is an efficient extraction technique for a wide range of analytes from various sample types. Bioactive components can be extracted rapidly, at low temperatures, with reduced energy and solvent requirements, making them a promising alternative to traditional methods. The UAE is also useful for extracting thermolabile and unstable compounds while preserving their functionality [46,47].
Accelerated solvent extraction (ASE) is an automated, eco-friendly extraction technique that has been shown to offer a number of advantages, including its speed and ease. It operates at high temperatures and pressures and utilizes a reduced number of solvents, thereby reducing analysis time and increasing extraction yield [48].
Membrane technologies—including microfiltration and ultrafiltration—offer effective alternatives to traditional methods for concentrating biologically active compounds. Membrane technologies enable selective separation and can be efficiently used for the purification and concentration of plant extracts to obtain high-quality products [49,50].
The present study analyzed the antidiabetic, anti-inflammatory, and cytotoxic activities of hydroalcoholic extracts enriched with polyphenols from S. aucuparia fruits collected in Romania. These fruits were selected due to their potential as a source of bioactive compounds with therapeutic and nutraceutical properties that have not been fully explored.

2. Materials and Methods

2.1. Chemicals and Reagents

Standards for chromatographic determinations (caffeic acid, coumaric acid, gallic acid, ellagic acid, chlorogenic acid, luteolin, kaempferol, quercetin, p-hydroxybenzoic acid, myricetin, quercitrin, quercetin 3-β-D-glucoside, rutin, and ascorbic acid) were purchased from Sigma-Aldrich (Darmstadt, Germany). Epicatechin, myricetin, and gallic acid were purchased from Fluka (Buchs, Switzerland). HPLC-grade reagents (methanol, ethanol, acetonitrile, and acetic acid (MeCN)) were purchased from Riedel-de Haen (GmbH, Seelze, Germany).

2.2. The Obtaining of the Extracts

To obtain the extracts, two modern, ecological, “green”, environmentally friendly methods were used: UAE and ASE.
Hydroalcoholic extracts, EtOH 50% (v/v) and 15% mass, were obtained from rowanberries collected in October 2024 from Ciungetu, Valcea County, at the geographical coordinates 45°23′14″ N 23°57′13″ E.
The fruits were well dried for several weeks in a convection oven (POLEKO, SWL 115, Wodzisław Śląski, Poland) at 40 °C. This temperature was chosen in order to minimize the impact on heat-sensitive bioactive compounds. After that, the dried material was ground using a Grindomix GM100 mill until a fine powder was obtained, with particle size < 300 µm (Retsch, Haan, Germany). The extracts were obtained through three methods: a traditional method (maceration) and two modern, ecological, and environmentally friendly methods, UAE and ASE.
The optimal conditions for carrying out the experiment and extracting high-yield polyphenols were established based on our previous studies [51].

2.2.1. Ultrasound-Assisted Extraction

For UAE, an Elma Transsonic T460 ultrasonic bath (frequency 35 kHz), made in Germany (Elma Schmidbauer GmbH & Co. KG, Singen, Germany), was used. A 50% (v/v) ethanol solution was added to the plant material, and the mixture was stirred for one hour at room temperature, before being ultrasonicated for 40 min at 60 °C. The extract was then filtered and stored at 4 °C.

2.2.2. Accelerated Solvent Extraction

An accelerated solvent extractor (ASE) system (Dionex ASE 350, Thermo Scientific, Waltham, MA, USA) was used for ASE extraction. Cellulose filters were placed in 100 mL stainless steel cells, into which 15 g of dried, ground plant material, pre-mixed with diatomaceous earth, was loaded.
The parameters used in the experiment were as follows: ethanol (50%, v/v), 60 °C, static time of 10 min, and three cycles. The extracts were collected in 200 mL glass vials and stored at 4 °C. The final concentration of the extracts was 15% (w/v).
The concentration of bioactive compounds was achieved using membrane technologies, micro- and ultrafiltration, using the KMS Laboratory Cell CF-1 laboratory facility. For microfiltration, membranes with a pore size of 0.45 µm were used, and for ultrafiltration, membranes with a pore size of 1000 Da and a pressure of 3–4 bar were used.

2.3. Analytical Methods

2.3.1. Total Polyphenols Determination (TPF) and Flavonoids Content (TFC)

The content of polyphenolic compounds in the extracts was analyzed using spectrophotometric and chromatographic methods.
The total polyphenol content of the obtained extracts was determined using the Folin–Ciocalteu method [52]. Calculations were performed using a chlorogenic acid calibration curve (y = 0.0016x + 0.013, R2 = 0.9945), and the results were expressed as chlorogenic acid equivalents (CAE) µg/mL.
The aluminum chloride spectrophotometric method was used to analyze the total flavonoid content (TFC) of the obtained extracts [53]. Calculations were performed using a rutin calibration curve (y = 0.0025x + 0.009, R2 = 0.9987), and the results were expressed as rutin equivalents (RE), µg/mL.
The following formula was used to calculate the extraction yield:
yield (%) = m1/m2 × 100, where m1 = the dry extract’mass and m2 = the sample’mass.

2.3.2. HPLC Analysis of Individual Phenolic Compounds

An HPLC Shimadzu system was used for the HPLC analysis. This system comprised a SIL-40CXR autosampler, a DGU-405 degasser, an LC-40DXR pump, a CTO-40C column oven (Shimadzu, Kyoto, Japan), and LC Solution software var. 5.1 Shimadzu. The HPLC was coupled to an LCMS-2050 mass spectrometer detector with a DUIS interface, with the following parameters: nebulizing gas flow, 2 L/min; drying gas flow, 5 L/min; heating gas flow, 7 L/min; desolvation line temperature, 200 °C; detector voltage, 0.7 kV; desolvation temperature, 450 °C; interface voltage, −2 kV; and nitrogen generator, Peak Scientific Genius XE Nitrogen.
An optimized method, previously reported by our team [54], was used in the chromatographic analysis. To perform these determinations, a C18 column, Kromasil 100–3.5-C18 2.1 × 100 mm, was used, with a mobile phase at pH = 3, consisting of 2 solvents: solvent A, water with formic acid, and solvent B, MeCN with formic acid. The mobile phase had a flow rate of 0.15 mL min-1 and was varied during the determinations, following a gradient elution program: 5–30% solvent B, 0–20 min; 30% solvent B, 20.01–35 min; 30–50% solvent B, 35.01–37 min; 50% solvent B, 42.01–45 min 50-5%; and 5% solvent B, 45–55 min, 5%. The negative ionization mode and selected ion monitoring (SIM) mode were used to examine the compounds of interest thanks to their specificity. In quantitative chromatographic analysis, the peak areas of the following fragment ions [M-H] were measured: 163, 609, 169, 285, 289, 137, 301, 317, 447, 463, 179, and 353.

2.4. Antioxidant Assays

The antioxidant capacity of the extracts was analyzed by three spectrophotometric methods.

2.4.1. DPPH Radical Scavenging Activity

The DPPH (2,2-diphenyl-1-picrylhydrazyl) assay was performed using a previously described method, with minor modifications [55]. The procedure was as follows: 1900 µL of methanol, together with 100 µL of extract and 1000 µL of 0.25 mM DPPH solution, were mixed and kept in the dark for 3 min, after which the absorbance was then read at 517. The following formula was used for the calculations:
Radical Scavenging Activity I (%) = [ (Acontrol − Asample)/Acontrol] × 100.
IC50 value was calculated, representing the concentration of antioxidant required to cause a 50% reduction in the initial DPPH concentration. An IC50 value of ≤50 µg/mL represents a good antioxidant capacity, whereas an IC50 value of ≥200 µg/mL reveals an insignificant antioxidant capacity [56].

2.4.2. Determination of Antioxidant Activity by Reducing Power

To determine the antioxidant activity of the extracts by reducing power, the method previously presented by Berker et al. was used [57]. Absorbance was determined at 700 nm, the standard used was ascorbic acid, and calculations were performed using the following formula:
Reducing power (%) = [(AA − AB)/AA] × 100
where AA = absorbance of sample and AB = absorbance of control.

2.4.3. ABTS Assay

For the ABTS assay, the Rice–Evans method was used with slight modifications; this method is based on the decrease in the ABTS absorbance of 2,2′-azino-bis (3-ethylbenzo-thiazoline-6-sulfonic acid) in the presence of an antioxidant at 731 nm [58]. Thus, to 100 mL of extract, 400 mL of distilled water and 2500 mL of ABTS solution (0.175 mM) were added, mixed, and kept in the dark for 3 min, and then the absorbance at 731 nm was read. The formula below was used for the calculations, and the data were expressed in TEAC equivalents (Trolox Equivalent Antioxidant Capacity):
TEAC sample   =   C T r o l o x f A s a m p l e A b l a n k A T r o l o x A b l a n k
where Ablank = control absorbance, ATrolox = Trolox absorbance, Asample = sample absorbance, f = dilution factor, and CTrolox = Trolox concentration.

2.5. Enzymes Inhibition Activity

The antidiabetic potential of S. aucuparia fruit extracts was assessed by testing their ability to inhibit α-amylase and α-glucosidase. Additionally, the extracts were evaluated for their ability to inhibit lipoxygenase and hyaluronidase, which could indicate anti-inflammatory potential.

2.5.1. Testing the Antidiabetic Potential of the Extracts

The antidiabetic potential of the extracts was evaluated by testing their ability to inhibit the digestive enzymes α-amylase and α-glucosidase, which are involved in carbohydrate metabolism.
  • Testing the α-amylase inhibition capacity
The α-amylase inhibition capacity was assayed using the Queiroz method, with minor modifications [59]. The procedure was as follows: 100 µL of extract was mixed with 250 µL of porcine pancreatic α-amylase (EC 3.2.1.1) (1 mg/mL), which was prepared in sodium phosphate buffer (0.02 M, pH 6.9) (Sigma-Aldrich, Steinheim, Germany). The mixture was then incubated at 37 °C for 20 min. Then, 250 µL of a 1% starch solution was added, after which the samples were re-incubated at 37 °C for a further 30 min. Finally, 500 µL of dinitrosalicylic acid (DNS) was added to the samples, which were then boiled for five minutes. Once cooled, 5 mL of distilled water was added to the reaction mixture, after which the absorbance was read at 540 nm using a Jasco V-630 UV-visible spectrophotometer. Acarbose was used as a standard, and the formula was used for calculations.
%   Amylase   inhibition = Δ A c o n t r o l Δ A s a m p l e Δ A c o n t r o l × 100
Linear regression analysis IC50 (µg/mL) was used to determine IC50 values. Differences in p < 0.05 are considered statistically significant.
  • α-Glucosidase Inhibition Assay
To test the ability of the extracts to inhibit α-glucosidase, the Ranilla et al. method was used with slight modifications [60]. The following procedure was followed: 120 µL of α-glucosidase (EC 3.2.1.20, Sigma-Aldrich, St. Louis, MO, USA) at a concentration of 0.5 U/mL, 720 µL of 0.1 M sodium phosphate-buffer solution (pH 6.9), and 60 µL of extract were mixed together and incubated at 37 °C for 15 min. Then, 120 µL of a p-nitrophenyl-α-D-glucopyranoside solution (5 mM/L) was added, and the mixture was re-incubated at 37 °C for a further 15 min. Finally, the absorbance was read at 405 nm. Acarbose was used as a standard, and calculations were performed using the following formula:
%   Glucosidase   inhibition   =   Δ A c o n t r o l Δ A s a m p l e Δ A c o n t r o l × 100
IC50 values were calculated, and differences in p < 0.05 are considered statistically significant.

2.5.2. Testing the Anti-Inflammatory Potential of the Extracts

The anti-inflammatory potential was tested by analyzing the ability of the extracts to inhibit LOX and HYA, two enzymes involved in the inflammatory process.
  • Hyaluronidase inhibition assay
The ability of the extracts to inhibit hyaluronidase was tested using the Morgan–Elson method, with minor modifications [61].
Hyaluronidase acts on hyaluronic acid, producing enzymatic hydrolysis products that react with p-dimethylaminobenzaldehyde to form a pink complex that can be measured using a spectrophotometer at a wavelength of 585 nm.
The procedure is as follows: Add 200 µL of 5% DMSO to 200 µL of extract (500 mg/mL) and 200 µL of enzyme solution (hyaluronidase, EC 3.2.1.35, from bovine testes—1 mg/mL, 4200 U/mL, Sigma-Aldrich Chemie GmbH, Steinheim, Germany).
Incubate at 37 °C for 20 min. Then add 200 µL of 12.5 mM CaCl2 and incubate the samples at 37 °C for a further 10 min. Then, 200 µL of a substrate solution of sodium hyaluronate in bovine vitreous humor (12 mg/mL in 0.1 M acetate buffer at pH 3.5) was added to the reaction mixture. The mixture was then incubated at 37 °C for 40 min. Next, 200 µL of 0.4 M NaOH and 400 µL of 0.2 M sodium borate were added, after which the mixture was incubated for three minutes at 100 °C to stop the reaction. Finally, 200 µL of 1% p-dimethylaminobenzaldehyde was added, after which the mixture was incubated for a further 10 min at 37 °C. The absorbance was then determined at 585 nm. A control sample was obtained under the same conditions, but with buffer solution instead of extract. Ibuprofen was used as the standard, and the following formula was used for calculations:
%   Hyaluronidase   inhibition   =   Δ A c o n t r o l Δ A s a m p l e Δ A c o n t r o l × 100
  • Lipoxygenase inhibition assay
Lipoxygenase inhibition capacity was tested according to a Sigma-Aldrich protocol [62]. The method is based on the formation of 13-hydroperoxyocta-decadienoic acid in the lipoxygenation reaction, which causes an increase in absorbance at 234 nm. Thus, to 100 μL extract, 1600 mL of 0.2 M borate buffer, pH = 9 and 100 mL of LOX solution (2750 U/mL) (EC 1.13.11.12, Sigma-Aldrich Chemie GmbH, Steinheim, Germany) were added, and it is maintained at room temperature for 15 min; finally, 200 μL of linoleic acid substrate (0.017% (v/v)) was added, and after 2 min, the absorbance was read at 234 ± 5 nm, corresponding to the maximum linear rate for the blank and the sample. The standard used was ibuprofen, and the calculations were made according to the formula:
%   Lipoxygenase   inhibition   =   Δ A c o n t r o l Δ A s a m p l e Δ A c o n t r o l × 100
Linear regression analysis IC50 (µg/mL) was used to determine IC50 values. Differences in p < 0.05 are considered statistically significant.

2.6. In Vitro Cytotoxicity Tests

The cytotoxic potential of the S. aucuparia fruit extracts was tested on the mouse fibroblast NCTC clone L929 cell line.

2.6.1. Cell Culture

L929 murine fibroblast cells (NCTC, clone L929) from ECACC (European Collection of Authenticated Cell Cultures, Salisbury, UK) were used to evaluate the in vitro cytotoxicity of S. aucuparia samples. These cells were chosen for the evaluation of cytotoxicity, as they are a standard reference cell line recommended by ISO 10993-5 [63] for the preliminary assessment of cytotoxicity and biocompatibility. This approach provides a reliable initial indication of general cytotoxicity. Specific media were used for cell cultivation, according to the suppliers’ recommendations; thus, a minimal essential medium (MEM) was used, to which 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin, neomycin and streptomycin) were added. The cells were kept under standard conditions at 37 °C and in an atmosphere containing 5% CO2.
In vitro tests were performed by seeding cells at a density of 5 × 104 cells/mL in 96-well cell culture plates, then, after 24 h of incubation, the samples were added. The cells were incubated under standard conditions, after which cell viability was assessed using the quantitative 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay at 24 and 48 h [64].

2.6.2. MTT Cell Viability Assay

To assess cell viability, the MTT assay was used as previously described [64]. For this assessment, 0.25 mg/mL MTT solution was added to the treated cells and then incubated at 37 °C for 3 h. Then, the insoluble formazan crystals were dissolved with isopropanol by incubation at room temperature for 15 min under gentle shaking. Absorbance measurement was performed at 570 nm using a SPECTROstar® Nano microplate reader (BMG Labtech, Ortenberg, Germany). There is a direct correlation between the amount of formazan and the number of metabolically active cells. Data were expressed as a percentage of viability compared to the untreated cells (control), which were considered to have 100% viability. Results represent the average of three determinations (mean ± standard deviation).

2.7. Statistical Analysis

Analysis of statistics was accomplished with Excel Office 365 (One Microsoft Way, Redmond, Washington, DC, USA), and the standard deviation (SD) was found to be less than 10%. The statistical analysis employed a Student’s t-test, with p-values less than 0.05 designated as statistically significant. The experiment sought to establish a correlation between the inhibitory activity of antioxidants and enzymes and the content of active principles. Also, the data were analyzed by a one-way repeated measures analysis of variance (RM ANOVA) and Tukey’s test, using the SigmaPlote 16.0 software.

3. Results and Discussions

3.1. Phytochemical Analysis and Antioxidant Capacity

The obtained extracts were analyzed for total polyphenols and flavonoids content using both spectrophotometric and HPLC-MS chromatographic methods, as well as for their antioxidant activity. The content of total polyphenols and flavonoids in the extracts determined spectrophotometric, and the extraction yield is presented in Table 1.
Two extraction methods were employed to determine the most effective approach for producing extracts with the highest polyphenol content. An increase in total polyphenols and flavones content, as well as in the extraction yield of the concentrated extracts compared to the initial microfiltered ones, reveals the efficiency of the ultrafiltration process.
ASE was found to be a more efficient method than UAE for extracting the target compounds from S. aucuparia (2692.53 ± 37.89 μg/mL CA equivalent for total polyphenols and 433.88 ± 21.12 μg/mL RU equivalent for the content of flavones). This is also evident from the superior extraction yields obtained by ASE, compared to UAE.
The high pressure and temperature used enable the solvent to penetrate the cell wall more effectively, likely enhancing ASE efficiency. Reducing the surface tension of the solvent releases the phenolic compounds more effectively, thus increasing the extraction efficiency [65].
UAE extraction affects plant cell walls, accelerating heat and mass transfer. This improves the kinetics and release of bioactive compounds, thereby increasing the extraction process yield [47].
The identification of polyphenolic compounds in the extracts was also carried out by chromatographic method, using the HPLC-MS. Good linearity of the method was observed within the studied concentration range (0.1–50 µg/mL). The results obtained regarding the concentrations of the polyphenolic compounds in the tested plant extracts are presented in Table 2 and Figure 1.
In the results obtained from ANOVA, it was observed that the differences in the median values among the treatment groups are greater than would be expected by chance; therefore, a Tukey’s test was also performed. Between the values obtained for microfiltrate extracts (ASE and UAE), concentrate extracts (ASE and UAE) show a significant difference. Also, between the values obtained for ASE extracts (microfiltrate and concentrate), for UAE extracts (microfiltrate and concentrate), the p-value is greater than the significance level (p < 0.050), and there is no statistically significant difference between the means of the two groups.
HPLC analysis revealed that the predominant polyphenolic compounds were chlorogenic acid (526.08 ± 23.35 µg/mL), rutin (36.07 ± 1.23 µg/mL), caffeic acid (34.41 ± 1.21 µg/mL), quercetin 3-β-D-glucoside (17.27 ± 0.56 µg/mL), p-hydroxybenzoic acid (15.09 ± 0.89 µg/mL), as well as epicatechin, quercitrin, and ellagic acid. The ASE method was more efficient at extracting the targeted compounds than UAE.
The ethanolic rowanberry extract contained high amounts of chlorogenic acid (3970 μg/g), which was higher than in the acetone and aqueous extracts [23]. The same study also found that ethanolic extract had the highest content of rutin, quercetin, and kaempherol-3-O-glucoside, compared to the acetone and aqueous extracts [23]. The main phenolic acids reported in Sorbus spp. and in S. aucuparia fruits are chlorogenic acids (3-O-caffeoylquinic acid, 3-CQA) and neochlorogenic acids (5-O-caffeoylquinic acid, 5-CQA) [23,66,67]. These acids represent 56–80% of the total phenolic compounds in Sorbus fruits and are present in higher quantities in wild fruits than in cultivated ones [21]. The amount of chlorogenic acids in Sorbus fruits is comparable to that in Arabica coffee beans, which are the richest known source of phenolic acids at 0.20 mg/g [68].
Polyphenols act at the cellular level through several mechanisms. One such mechanism is binding to cellular receptors and transcription factors (e.g., Nrf2, NF-κB and AP-1), thereby influencing gene expression [69].
Another mechanism by which polyphenols act is by affecting the expression of microRNAs (miRNAs), which play a role in post-transcriptional regulation as small, non-coding RNAs. This may have implications for cancer, neurodegenerative diseases, and cardiovascular diseases [70].
Polyphenols can also affect the fluidity and permeability of cell membranes, thereby influencing membrane-bound enzymes and receptors, as well as signal transmission and intercellular communication [71].
Caffeoylquinic acids have been reported in Sorbus fruits and leaves, although in lower quantities than in inflorescences [72].
The presence of polyphenolic compounds such as chlorogenic acid, hyperin, rutin, catechin, epicatechin, quercetin, and isoquercetin has been reported in rowanberries [12,21].
Another study found that the predominant polyphenolic compounds in rowanberries are isomers of caffeoylquinic acids, with quercetin 3-O-(6-malonyl)-glucoside accounting for over 50% of the flavonols [73].
Other studies have reported the presence of flavonols, such as quercetin, rutin, hyperoside, and isoquercetin glycosides, as well as hydroxycinnamic acids and their derivatives [22,74].
Polyphenolic compounds such as apigenin, baicalin, rutin, kaempferol, scutellariae, isoquercetin, and cinidine-3-O-glucoside, as well as chlorogenic acid, caffeic acid, gallic acid, p-coumaric acid, vanillic acid, and ferulic acid have been determined in 40% ethanolic extracts of S. acuparia fruits [75].
Due to the complexity of polyphenolic compounds, several analytical methods are typically employed to assess the antioxidant activity of extracts. In this study, three methods were used to determine antioxidant activity: DPPH, reducing power, and ABTS. These methods are the most common due to their high degree of reproducibility [76]. The results, expressed as IC50 for DPPH and reducing power assays and as TEAC equivalents for ABTS, are presented in Table 3.
ASE extracts exhibited superior antioxidant activity compared to UAE. Concentrated extracts demonstrated higher antioxidant activity in comparison to microfiltered extracts, correlated with the content of bioactive compounds (polyphenols and flavones). The existence of a positive correlation between the content of polyphenolic compounds and antioxidant activity has been highlighted by many authors [19,67,68]. In vitro chemical tests, such as DPPH/ABTS+, have been very popular in this field and have highlighted the existence of this correlation [69]. In the DPPH analysis, the ASE extract exhibited even higher antioxidant activity than the standard (vitamin C). The IC50 value of ASEconc extract was 39.07 ± 0.32 µg/mL in comparison to 46.47 ± 1.38 µg/mL for vitamin C. Moreover, the microfiltered ASE extract showed higher antioxidant activity in comparison to the standard. In the reducing power analysis, the concentrated extracts demonstrated comparable antioxidant activity (IC50ASEconc was 47.36 ± 1.65 µg/mL; IC50 USconc was 49.61 ± 1.21 µg/mL), which was lower than the standard used—IC50 vitamin C was 36.32 ± 1.25 µg/mL. When tested by the ABTS method, the ASE extract also demonstrated the most efficacious antioxidant activity. TEAC_ABTS of ASEconc value was 50.81 ± 2.87 μmol Trolox/g in comparison to the UAE extracts; however, this was still lower than the standard, which had a TEAC_ABTS of vitamin C value of 68.61 ± 2.32 µg/mLTrolox/g.
Studies have reported that rowanberry extracts exhibit antioxidant activity [77], comparable to that of other edible berries such as chokeberries and bilberries [78].
The antioxidant activity of fruits from the genus Sorbus has been confirmed in S. aucuparia, S. domestica, and S. torminalis [11].
When the antioxidant activity of the extract was evaluated using the DPPH test, S. aucuparia and S. caucasica var. yaltirikii exhibited SC50 values of 0.366 ± 0.009 mg/mL and 0.520 ± 0.023 mg/mL, respectively. These values are comparable to those of the standards used: gallic acid, chlorogenic acid, and quercetin [79].
Methanolic extracts from S. aucuparia fruits have been demonstrated to possess antiradical properties, with an inhibition percentage of 16.33 ± 0.96% against hydroxyl radicals, 26.74 ± 1.75% against superoxide anions, and 25.17 ± 1.72% against nitric oxides [80].
The antioxidant properties of the rowanberry are attributable to the presence of polyphenolic compounds, especially chlorogenic acids, flavonols (e.g., quercetin, isoquercetin, rutin, catechin, and epicatechin), as well as anthocyanins and proanthocyanidins [19,21].
Chlorogenic acid (CA) exhibits a variety of important therapeutic properties, including anti-inflammatory, antioxidant, antiviral, and antibacterial effects [81]. CA is a well-known antiradical agent, which was first isolated from coffee beans, where it is found in the highest concentration. CA plays a protective role in pathologies associated with oxidative stress, including neurological, cardiovascular, and cancer [71,82].
Quercetin is a potent antioxidant with protective effects against tissue damage caused by the toxicity of various drugs [83], as well as anti-inflammatory, antidiabetic, and antiviral properties [71].

3.2. Testing Antidiabetic Potential—α-Amylase and α-Glucosidase Inhibition

The antidiabetic potential of the obtained extracts was evaluated by testing their capacity to inhibit α-amylase and α-glucosidase enzymes. The inhibitory capacity of α-amylase and α-glucosidase was compared with the content of polyphenols and flavones. The data were analyzed by Student’s test, and the values of p < 0.05 were obtained. The results obtained are presented in Table 4.
In the analysis of the α-amylase and α-glucosidase inhibition capacity of S. aucuparia fruit extracts, it was observed that the concentrated extracts exhibited higher inhibitory activity in comparison to the initial microfiltrates. The ASE extracts demonstrated higher inhibition than the UAE extracts. The concentrated extracts showed α-amylase inhibition activity that was comparable to that of the standard; specifically, the IC50 of the concentrated ASE extract was 23.74 ± 1.32 µg/mL, and the IC50 of acarbose was 22.65 ± 1.27 µg/mL. Conversely, the UAE concentrated extract exhibited slightly lower activity than the standard, with an IC50 UAEconc of 38.23 ± 2.53 µg/mL.
The extracts obtained by ASE demonstrated inhibitory activity on α-glucosidase that was higher than the standard. This activity was observed in both the microfiltered and concentrated extracts. The most effective inhibition was recorded in the concentrated ASE extract, with the IC50 of the ASEconc being 13.50 ± 0.96 µg/mL, lower than that of the standard (20.19 ± 1.67 ug/mL). The inhibitory activity of the extracts from UAE on α-glucosidase was found to be lower than that of the standard that was utilized.
The method employed in this study, ASE, was found to be more efficacious than UAE. This led to an extract containing a higher quantity of bioactive compounds and a higher inhibition yield on the analyzed enzymes. This phenomenon is probably due to the high pressure and temperature, which enhance the extraction process by increasing the diffusion rate of bioactive compounds, as evidenced in other studies [84]. The solvent used for extraction was 50% ethanol, which was also used in previous studies. This solvent led to higher extraction yields in comparison with other solvents, including methanol, acetone, and water [85]. While increasing solvent polarity generally improves extraction, moderately polar solvents like 50% ethanol produce higher yields when compared with absolute ethanol [85].
Among the species of the genus Sorbus, the most extensively studied for its antidiabetic effects is S. decora, whose bark is traditionally used in folk medicine. Subsequent in vivo and in vitro studies have confirmed the antidiabetic activity of S. decora bark [11]. Few studies have been conducted on Sorbus fruits (rowanberry) to test antidiabetic activity.
As demonstrated in earlier studies, rowanberry extracts have been shown to possess the capacity to inhibit enzymes involved in the process of carbohydrate digestion, namely, α-amylase, and α-glucosidase, especially extracts rich in chlorogenic acids and proanthocyanidins [86].
Research has demonstrated that chlorogenic acid exerts a regulatory effect on lipid and carbohydrate metabolism, suggesting its potential application in the treatment of hepatic steatosis, cardiovascular diseases, obesity, and even diabetes [81].
Chlorogenic acids have been associated with a reduced risk of type 2 diabetes. They hydrolyze to produce caffeic acid, which decreases glucose absorption, lowers glucose production in the liver, and mitigates oxidative stress in vitro [72].
The aqueous extract of S. aucuparia fruits, which is rich in polyphenolic compounds, demonstrated inhibitory activity on α-glucosidase (IC50 was 30 μg/mL) comparable to that of acarbose; the extract exhibited a predominant content of chlorogenic acid, over 65% of the total polyphenols [84].
The efficacy of Sorbus fruit extracts in reducing blood sugar levels and insulin resistance has also been demonstrated in vivo in mice [87].
As demonstrated in [30], several species within the genus Sorbus, including S. norvegica, S. folgneri, S. alnifolia, and S. aucuparia, have been shown to possess inhibitory activity on both α-amylase and α-glucosidase. The inhibitory activity was also confirmed in the case of S. norvegica fruits by in vivo studies. The antihyperglycemic effect in mice was 36 times lower than that of acarbose, and both the polyphenolic fraction and the carbohydrate fraction contributed to the inhibitory potential [30].
Rowanberries have been utilized in folk medicine for the treatment of diabetes and in the prophylaxis of cardiovascular diseases [15]. The mechanisms of action underlying these properties, as well as the phytochemical composition of S. aucuparia fruits, are not fully known [88].
It has been hypothesized by other studies that polyphenolic compounds may intervene in the modulation of carbohydrate metabolism by inhibiting digestive enzymes such as α-amylase and α-glucosidase, as well as modulating the expression of cytokines involved in the inflammatory process [89,90]. Moreover, polyphenols have been demonstrated to modulate the activity of enzymes such as cyclooxygenase and lipoxygenase, thereby enhancing their anti-inflammatory and chemopreventive properties [91].

3.3. Testing Anti-Inflammatory Potential—Lipoxygenase (LOX) and Hyaluronidase (HYA) Inhibition Activity

The anti-inflammatory potential of the obtained extracts was evaluated by testing their inhibitory capacity on LOX and HYA enzymes. These enzymes form the basis of many synthetic anti-inflammatory drugs. However, plant extracts, particularly those rich in phenolic compounds, can also significantly inhibit their activity [27]. The inhibitory capacity on LOX and HYA was compared with polyphenols and flavones content using Student’s test, and values were determined with p < 0.05. The results obtained are shown in Table 5.
The increased efficiency of the ASE method, compared to UAE, as well as the efficiency of the ultrafiltration process, was also evident when testing the inhibitory capacity of the extracts on LOX and HYA. Consequently, ASE extracts demonstrated inhibitory activity on LOX and HYA, which was superior to that of UAE extracts. Furthermore, concentrated extracts exhibited higher efficacy than microfiltrates.
The tested extracts, which were found to be rich in polyphenols, demonstrated the potential to inhibit the activity of the tested enzymes. Consequently, the concentrated extract_ASE demonstrated the most significant inhibitory activity on LOX, as outlined below: the IC50ASEconc was found to be 24.30 ± 1.54 µg/mL, which is higher than the standard used. The IC50ibuprofen was 26.91 ± 1.27 µg/mL, while the UAE extract showed inhibition close to the standard of 31.01 ± 2.36 µg/mL.
With regard to the inhibition of HYA, both concentrated extracts demonstrated inhibitory activities higher than the standard, as follows: the IC50ASEconc was found to be 43.04 ± 2.19 µg/mL, and IC50UAEconc was found to be 48.49 ± 3.15 µg/mL, in comparison to the IC50 of ibuprofen, which was 51.54 ± 3.67 µg/mL.
The significant anti-inflammatory activity of S. aucuparia extracts may be attributed to their high polyphenol content, particularly chlorogenic acid, a well-known bioactive compound with anti-inflammatory and antioxidant properties. Chlorogenic acid (CA) exerts its anti-inflammatory effects by regulating the production and release of inflammatory mediators such as TNF-α, IL-1β, IL-6, IL-8, NO, and PGE2, which play crucial roles in the initiation and progression of the inflammatory response [92].
Methanol–water extracts of S. domestica leaves exhibited LOX inhibitory effect, with an IC50 of 115.54 ± 4.99 mg/mL, comparable to the IC50 of indomethacin (92.60 ± 3.71 mg/mL). Similarly, extracts demonstrated HYA inhibitory activity, with an IC50 of 11.06 ± 0.30 mg/mL, which is also comparable to the IC50 of indomethacin (12.77 ± 0.91 mg/mL). The activity of the extracts in the LOX assay was found to be strongly dependent on the total polyphenol content (r = −0.8969, p < 0.05); the results in the HYA assay were only slightly dependent on the total polyphenol content (r = −0.3832, p > 0.05), but strongly determined by proanthocyanidins (TPA; r = −0.8843, p < 0.05) [27].
In another study, methanolic extracts from S. domestica leaves demonstrated inhibitory activity against both enzymes, with a stronger effect on LOX—principally due to quercetin and procyanidin—than on HYA, which was mainly influenced by catechins and procyanidins [27]. These effects were comparable to those of the standard reference, indomethacin [93]. Methanolic extracts from S. aucuparia flowers exhibited a significant HYA inhibitory effect, surpassing that of indomethacin [94].
The anti-inflammatory activity of S. commixta has been confirmed both in vitro and in vivo, with in vivo results comparable to those of ibuprofen [95,96].
Moderate anti-inflammatory activity on lipoxygenase was also revealed by S. cashmiriana, which was attributed to two triterpenes, cashmirol A and cashmirol B, with exhibited IC50 values of 90.2 μM and 74.9 μM, respectively, (compared to baicalein used as a positive control, with an IC50 of 8.0 lM) [97].

3.4. Cytocompatibility of S. aucuparia Samples

The results obtained from the MTT assay, which was used to determine cell viability, are presented in Figure 2. Sample viability was reported relative to the control group (untreated cells), which was considered to have 100% viability. Experiments were conducted to establish the dose–response relationship over a concentration range of 0–1000 μg/mL, with incubation periods of 24 and 48 h.
Cytotoxicity evaluation of the ASE samples (Figure 2A) showed that after 24 h of treatment, the ASE_MF extract was cytocompatible across the entire tested concentration range (0–1000 µg/mL), maintaining cell viability above 80%. In contrast, treatment with the ASE_C extract resulted in a significant decrease in cell viability, with a notable drop to 54% observed at a concentration of 750 µg/mL and 39% at a concentration of 1000 µg/mL.
After 48 h of exposure, a dose-dependent decrease in cell viability was observed for both extracts. At concentrations ranging from 0 to 250 µg/mL, viability remained above 77% for both ASE variants. However, at 500 µg/mL, cell viability decreased to 74% for ASE_MF and further dropped to 38% for ASE_C. The highest concentrations tested (750 and 1000 µg/mL) were cytotoxic, with cell viability being below 38% for both variants.
Regarding samples (Figure 2B), cytotoxicity evaluation showed that after 24 h of treatment, both UAE extracts were cytocompatible across the entire tested concentration range (0–1000 µg/mL), with cell viability values exceeding 77%, except for the UAE_C sample, which resulted in a decline in cell viability to 58%.
After 48 h of treatment, all UAE variants remained cytocompatible within the concentration range of 0-250 µg/mL. Treatment with the UAE_C extract resulted in similar viability rates of 61% and 58% at concentrations of 500 µg/mL and 750 µg/mL, respectively, while the highest concentration reduced viability to only 20%. Conversely, exposure to the UAE_MF extract resulted in elevated cell viability across all concentrations examined, maintaining levels above 67% even at a concentration of 1000 µg/mL.
Literature data indicate that the fruits and seeds of S. aucuparia contain parasorbic acid, a toxic compound that can cause digestive and renal problems [98]. This compound is thermolabile and decomposes into harmless sorbic acid when the fruits are harvested after freezing [77]. The compound is almost absent in cultivated species [72]. Another toxic compound present in rowanberry seeds is prunasin, a cyanogenic glycoside that can release HCN (1g of prunasin can release 91.5 mg HCN). A concentration of 2–3 mg/L of HCN has been shown to cause respiratory problems and even death; therefore, it is recommended that seeds be removed during the processing of S. aucuparia fruits [72].
One possible explanation for the low viability of the analyzed samples after 48 h could be the presence of toxic compounds such as parasorbic acid and prunasin. These shortcomings could be eliminated by freezing the fruit prior to use; however, we worked with fresh fruit, meaning that parasorbic acid had not yet been transformed into the harmless sorbic acid. Prunasin, on the other hand, is present in the seeds. Using seedless fruit would resolve this problem.

4. Conclusions

The fruit extracts of S. aucuparia obtained and analyzed in this study, particularly the ASE concentrates, demonstrated promising antioxidant activity as well as significant enzymatic inhibition of α-glucosidase, α-amylase, LOX, and HYA. The concentrated ASE extract of S. aucuparia exhibited the highest levels of polyphenols (2692.53 ± 37.89 CA mg/mL) and flavonoids (433.88 ± 21.12 RU mg/mL), along with strong inhibitory effects on the enzymes studied. The IC50 values for IC50α-glucosidase, IC50α-amylase, and IC50LOX were determined to be 13.50 ± 0.96 µg/mL, 20.19 ± 1.67 µg/mL, and 23.74 ± 1.32 µg/mL, respectively. The IC50 values for IC50HYA and IC50ibuprofen were determined to be 43.04 ± 2.19 µg/mL and 51.54 ± 3.67 µg/mL, respectively.
The data obtained provide scientific support for the use of these fruits in folk medicine for managing diabetes and inflammatory diseases; however, further in vivo studies are needed to confirm these activities. Due to their significant content of polyphenolic compounds, especially chlorogenic acid isomers, which are recognized as powerful antioxidants with beneficial health effects, S. aucuparia fruits could be valuable in developing medicinal products, nutraceuticals, or functional foods targeting diabetes and inflammatory diseases.

Author Contributions

Conceptualization, E.N. and G.P.; methodology: E.N., G.P., C.A. and A.M.S.-G.; investigation, E.N., G.P., C.A. and A.M.S.-G.; supervision, G.L.R. and C.A.; writing—original draft preparation, E.N., writing—review and editing, E.N., G.P., C.A. and G.B. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the Ministry of Research, Innovation, and Digitalization through 75 PHE/ 2024 Project, PN-IV-P8-8.1-PRE-HE-ORG-2024-0193 (the European Commission’s Innovation Research Framework/PN IV European and international cooperation program) and the Core Program of the National Research, Development, and Innovation Plan 2022-2027, project no. PN 23-02-0101-Contract No. 7N/2023.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
UAEUltrasound-assisted extraction
ASEAccelerated solvent extraction
HPLC-MSHigh performance liquid chromatography—mass spectrometry
HYAHyaluronidase
LOXLipoxygenase
TEACTrolox Equivalent Antioxidant Capacity
SDStandard deviation

References

  1. Adhikari, B.; Marasini, B.P.; Rayamajhee, B.; Bhattarai, B.R.; Lamichhane, G.; Khadayat, K.; Adhikari, A.; Khanal, S.; Parajuli, N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phyther. Res. 2021, 35, 1298–1312. [Google Scholar] [CrossRef]
  2. Pereira, C.; Barros, L.; Santos-Bruega, C.; Prieto, A.M. Natural bioactives used as additives in food applications. Front. Nutr. 2022, 9, 1063942. [Google Scholar] [CrossRef]
  3. Anunciato, T.P.; da Rocha Filho, P.A. Carotenoids and polyphenols in nutricosmetics, nutraceuticals, and cosmeceuticals. J. Cosmet. Dermatol. 2012, 11, 51–54. [Google Scholar] [CrossRef]
  4. Zhang, R.; McClements, D.J. Enhancing nutraceutical bioavailability by controlling the composition and structure of gastrointestinal contents: Emulsionbased delivery and excipient systems. Food Struct. 2016, 10, 21–36. [Google Scholar] [CrossRef]
  5. Al Ali, M.; Alqubaisy, M.; Aljaafari, M.N.; Al Ali, A.O.; Baqais, L.; Molouki, A.; Abushelaibi, A.; Lai, K.S.; Lim, S.E. Nutraceuticals: Transformation of conventional foods into health promoters/disease preventers and safety considerations. Molecules 2021, 26, 2540. [Google Scholar] [CrossRef] [PubMed]
  6. Nasri, H.; Baradaran, A.; Shirzad, H.; Rafieian-Kopaei, M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014, 5, 1487–1499. [Google Scholar] [PubMed]
  7. Pitchaiah, G.; Akula, A.; Chandi, V. Anticancer Potential of Nutraceutical Formulations in MNU-induced Mammary Cancer in Sprague Dawley Rats. Pharmacogn. Mag. 2017, 13, 46–50. [Google Scholar]
  8. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017, 9, 1211. [Google Scholar] [CrossRef]
  9. Affuso, F.; Ruvolo, A.; Micillo, F.; Sacc, L.; Fazio, S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr. Metab. Cardiovasc. Dis. NMCD 2010, 20, 656–661. [Google Scholar] [CrossRef]
  10. Ruchi, S.; Amanjot, K.; Sourav, T.; Keerti, B.; Sujit, B. Role of nutraceuticals in health care: A review. Int. J. Green Pharm. 2017, 11, 386–394. [Google Scholar]
  11. Sołtys, A.; Galanty, A.; Podolak, I. Ethnopharmacologically important but underestimated genus Sorbus: A comprehensive review. Phytochem. Rev. 2020, 19, 491–526. [Google Scholar] [CrossRef]
  12. Olszewska, M.A.; Presler, A.; Michel, P. Profiling of phenolic compounds and antioxidant activity of dry extracts from the selected Sorbus species. Molecules 2012, 17, 3093–3113. [Google Scholar] [CrossRef]
  13. Polat, R.; Satıl, F. An ethnobotanical survey of medicinal plants in Edremit Gulf (Balikesir–Turkey). J. Ethnopharmacol. 2012, 139, 626–641. [Google Scholar] [CrossRef] [PubMed]
  14. Vogl, S.; Picker, P.; Mihaly-Bison, J.; Fakhrudin, N.; Atanasov, A.G.; Heiss, E.H.; Wawrosch, C.; Reznicek, G.; Dirsch, V.M.; Saukel, J.; et al. Ethnopharmacological in vitro studies on Austria’s folk medicine—An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs. J. Ethnopharmacol. 2013, 149, 750–771. [Google Scholar] [CrossRef] [PubMed]
  15. Shikov, A.N.; Pozharitskaya, O.N.; Makarov, V.G.; Wagner, H.; Verpoorte, R.; Heinrich, M. Medicinal plants of the Russian Pharmacopoeia; their history and applications. J. Ethnopharmacol. 2014, 154, 481–536. [Google Scholar] [CrossRef]
  16. Pranskuniene, Z.; Ratkeviciute, K.; Simaitiene, Z.; Pranskunas, A.; Bernatoniene, J. Ethnobotanical study of cultivated plants in Kaišiadorys District, Lithuania: Possible trends for new herbal based medicines. Evid. Based. Complement. Altern. Med. 2019, 3940397. [Google Scholar] [CrossRef]
  17. Sak, K.; Jürisoo, K.; Raal, A. Estonian folk traditional experiences on natural anticancer remedies: From past to the future. Pharm. Biol. 2014, 52, 855–866. [Google Scholar] [CrossRef]
  18. Neves, J.M.; Matos, C.; Moutinho, C.; Queiroz, G.; Gomes, L.R. Ethnopharmacological notes about ancient uses of medicinal plants in Trás-os-Montes (northern of Portugal). J. Ethnopharmacol. 2009, 124, 270–283. [Google Scholar] [CrossRef]
  19. Olszewska, M.A. Variation in the phenolic content and in vitro antioxidant activity of Sorbus aucuparia leaf extracts during vegetation. Acta Pol. Pharm. Drug Res. 2011, 68, 937–944. [Google Scholar]
  20. Gaivelyte, K.; Jakstas, V.; Razukas, A.; Janulis, V. Variation in the contents of neochlorogenic acid, chlorogenic acid and three quercetin glycosides in leaves and fruits of Rowan (Sorbus) species and varieties from collections in Lithuania. Nat. Prod. Commun. 2013, 8, 1105–1110. [Google Scholar] [CrossRef]
  21. Kylli, P.; Nohynek, L.; Puupponen-Pimiä, R.; Westerlund-Wikstrom, B.; McDougall, G.; Stewart, D.; Heinonen, M. Rowanberry phenolics: Compositional analysis and bioactivities. J. Agric. Food Chem. 2010, 58, 11985–11992. [Google Scholar] [CrossRef]
  22. Zymone, K.; Raudone, L.; Raudonis, R.; Marksa, M.; Ivanauskas, L.; Janulis, V. Phytochemical profiling of fruit powders of twenty Sorbus L. cultivars. Molecules 2018, 23, 2593. [Google Scholar] [CrossRef]
  23. Bobinaitė, R.; Grootaert, C.; Van Camp, J.; Šarkinas, A.; Liaudanskas, M.; Žvikas, V.; Viškelis, P.; Venskutonis, P.R. Chemical composition, antioxidant, antimicrobial and antiproliferative activities of the extracts isolated from the pomace of rowanberry (Sorbus aucuparia L.). Food Res. Intern. 2020, 136, 109310. [Google Scholar] [CrossRef]
  24. Yang, B.; Kortesniemi, M. Clinical evidence on potential health benefits of berries. Curr. Opin. Food Sci. 2015, 2, 36–42. [Google Scholar] [CrossRef]
  25. Baby, B.; Antony, P.; Vijayan, R. Antioxidant and anticancer properties of berries. Cri. Rev. Food Sci. Nutr. 2018, 58, 2491–2507. [Google Scholar] [CrossRef] [PubMed]
  26. Skrovankova, S.; Sumczynski, D.; Mlcek, J.; Jurikova, T.; Sochor, J. Bioactive compounds and antioxidant activity in different types of berries. Int. J. Moi. Sci. 2015, 16, 24673–24706. [Google Scholar] [CrossRef]
  27. Matczak, M.; Michel Marchelak, A.P.; Owczarek, A.; Piszczan, A.; Kolodziejczyk-Czepas, J.; Nowak, P.; Olszewska, M.A. Sorbus domestica L. leaf extracts as functional products: Phytochemical profiling, cellular safety, pro-inflammatory enzymes inhibition and protective effects against oxidative stress in vitro. J. Funct. Foods. 2018, 40, 207–218. [Google Scholar] [CrossRef]
  28. Juan, C.A.; Pérez de la Lastra, J.M.; Plou, F.J.; Pérez-Lebeña, E. The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci. 2021, 22, 4642. [Google Scholar] [CrossRef] [PubMed]
  29. Biswas, S.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxidative Med. Cell. Longev. 2016, 2016, 5698931. [Google Scholar] [CrossRef] [PubMed]
  30. Broholm, S.L.; Gramsbergen, S.M.; Nyberg, N.T.; Jager, A.K.; Staerk, D. Potential of Sorbus berry extracts for management of type 2 diabetes: Metabolomics investigation of 1H NMR spectra, α-amylase and α-glucosidase inhibitory activities, and in vivo anti-hyperglycaemic activity of S. norvegica. J. Ethnopharmacol. 2019, 242, 112061. [Google Scholar] [CrossRef]
  31. Xiao, J.; Högger, P. Dietary polyphenols and type 2 diabetes: Current insights and future perspectives. Curr. Med. Chem. 2015, 22, 23–38. [Google Scholar] [CrossRef]
  32. Edirisinghe, I.; Burton-Freeman, B. Anti-diabetic actions of Berry polyphenols—Review on proposed mechanisms of action. J. Berry Res. 2016, 6, 237–250. [Google Scholar] [CrossRef]
  33. Kato-Schwartz, C.G.; Corrêa, R.C.G.; Lima, D.S.; Sá-Nakanishi, A.B.; Gonçalves, G.A.; Seixas, F.A.V.; Haminiuk, C.W.I.; Barros, L.; Ferreira, I.C.F.R.; Bracht, A.; et al. Potential anti-diabetic properties of Merlot grape pomace extract: An in vitro, in silico and in vivo study of α-amylase and α-glucosidase inhibition. Food Res. Intern. 2020, 137, 109462. [Google Scholar] [CrossRef] [PubMed]
  34. Sajid, A.; Afzal, M.; Sajid, A.; Manzoor, Q.; Ahmed, E.; Sharif, A.; Younas, S. NMR structure elucidation and molecular modeling of lipoxygenase and cholinesterase inhibiting steroids from Hypericum oblongifolium. Curr. Org. Chem. 2022, 26, 1798–1806. [Google Scholar] [CrossRef]
  35. Loncaric, M.; Strelec, I.; Moslavac, T.; Subaric, D.; Pavic, V.; Molnar, M. Lipoxygenase inhibition by plant extracts. Biomolecules 2021, 11, 152. [Google Scholar] [CrossRef]
  36. González-Peña, D.; Colina-Coca, C.; Char, C.D.; Cano, M.P.; Ancos, B.; Sánchez-Moreno, C. Hyaluronidase inhibiting activity and radical scavenging potential of flavonols in processed onion. J. Agric. Food Chem. 2013, 61, 4862–4872. [Google Scholar] [CrossRef]
  37. Sajid, A.; Sajid, A.; Ahmed, E.; Sharif, A.; Manzoor, Q.; Al-Mijalli, S.H.; Iqbal, M. In-vitro and molecular docking studies of plant secondary metabolites isolated from Hypericum oblongifolium as antibacterial agents and lipoxygenase (5-LOX) inhibitors. J. Mol. Struct. 2024, 1312, 138549. [Google Scholar] [CrossRef]
  38. Hu, C.; Ma, S. Recent development of lipoxygenase inhibitors as anti-inflammatory agents. Med. Chem. Commun. 2018, 9, 212–225. [Google Scholar] [CrossRef]
  39. Perera, H.D.S.M.; Samarasekeraa, J.K.R.R.; Handunnettib, S.M.; Weerasenaba, O.V.D.S.J. In vitro anti-inflammatory and anti-oxidant activities of Sri Lankan medicinal plants. Ind. Crops Prod. 2016, 94, 610–620. [Google Scholar] [CrossRef]
  40. Steinhilber, D.; Hofmann, B. Recent advances in the search for novel5-lipoxygenase inhibitors. Basic Clin. Pharmacol. Toxicol. 2014, 114, 70–77. [Google Scholar] [CrossRef]
  41. Liyanaarachchia, G.D.; Samarasekeraa, J.K.R.R.; Mahanamab, K.R.R.; Hemalal, K.D.P. Tyrosinase, elastase, hyaluronidase, inhibitory and antioxidant activity of Sri Lankan medicinal plants for novel cosmeceuticals. Ind. Crops Prod. 2018, 111, 597–605. [Google Scholar] [CrossRef]
  42. Girish, K.S.; Kemparaju, K.; Nagaraju, S.; Vishwanath, B.S. Hyaluronidase inhibitors: A biological and therapeutic perspective. Curr. Med. Chem. 2009, 16, 2261–2288. [Google Scholar] [CrossRef]
  43. Sudha, P.N.; Rose, M.H. Beneficial effects of hyaluronic acid. Adv. Food Nutr. Res. 2014, 72, 137–176. [Google Scholar]
  44. Ölgen, S.; Kaessler, A.; Zühal Kiliç-Kurt, Z.; Jose, J. Investigation of aminomethyl indole derivatives as hyaluronidase inhibitors. Z. Naturforschung C 2014, 65, 445–450. [Google Scholar] [CrossRef] [PubMed]
  45. Michalea, R.; Stathopoulou, K.; Polychronopoulos, P.; Benaki, D.; Mikros, E.; Aligiannis, N. Efficient identification of Acetylcholinesterase and Hyaluronidase inhibitors from Paeonia parnassica extracts through a Hetero Covariance Approach. J. Ethnopharmacol. 2020, 257, 111547. [Google Scholar] [CrossRef]
  46. Zhang, Q.W.; Lin, L.G.; Ye, W.C. Techniques for extraction and isolation of natural products: A comprehensive review. Chin. Med. 2018, 13, 20. [Google Scholar] [CrossRef]
  47. Kumar, K.; Srivastav, S.; Sharanagat, V.S. Ultrasound assisted extraction (UAE) of bioactive compounds from fruit and vegetable processing by-products: A review. Ultrason. Sonochem. 2021, 70, 105325. [Google Scholar] [CrossRef] [PubMed]
  48. Cano-Lamadrid, M.; Mozafari, L.; Martínez-Zamora, L.; Lorca, F.; García-Gomez, P.; Artes-Hernandez, F. Obtaining carotenoid encapsulates with polysaccharides carriers after pilot scale accelerated solvent extraction and ultrasound-assisted extraction from, industrial tomato by-product. Food Res. Int. 2025, 203, 115908. [Google Scholar] [CrossRef]
  49. Bazinet, L.; Doyen, A. Antioxidants, mechanisms, and recovery by membrane processes. Crit. Rev. Food Sci. Nutr. 2017, 57, 677–700. [Google Scholar] [CrossRef]
  50. Conidi, C.; Drioli, E.; Cassano, A. Membrane-based agro-food production processes for polyphenol separation, purification and concentration. Curr. Opin. Food Sci. 2018, 17, 149–164. [Google Scholar] [CrossRef]
  51. Paun, G.; Neagu, E.; Alecu, A.; Albu, C.; Seciu-Grama, A.-M.; Radu, G.L. Evaluating the Antioxidant and Antidiabetic Properties of Medicago sativa and Solidago virgaurea Polyphenolic-Rich Extracts. Molecules 2024, 29, 326. [Google Scholar] [CrossRef] [PubMed]
  52. Singleton, V.L.; Orthofer, R.; Lamuela-Raventos, R.M. Analysis of Total Phenols and Other Oxidation Substrates and Antioxidants by Means of Folin-Ciocalteu Reagent. In Methods Enzymology; Academic Press: San Diego, CA, USA, 1999; Volume 299, pp. 152–178. [Google Scholar]
  53. Lin, J.-Y.; Tang, C.-Y. Determination of total phenolic and flavonoid contents in selected fruits and vegetables, as well as their stimulatory effects on mouse splenocyte proliferation. Food Chem. 2007, 101, 140–147. [Google Scholar] [CrossRef]
  54. Neagu, E.; Paun, G.; Albu, C.; Eremia, S.A.-M.V.; Radu, G.L. Artemisia abrotanum and Symphytum officinale Polyphenolic Compounds-Rich Extracts with Potential Application in Diabetes Management. Metabolites 2023, 13, 354. [Google Scholar] [CrossRef] [PubMed]
  55. Bondet, V.; Brand-Williams, W.; Berset, C. Kinetics and mechanism of antioxidant activity using the DPPH free radical method. LWT Food Sci. Technol. 1997, 30, 609–615. [Google Scholar] [CrossRef]
  56. Epure, A.; Pârvu, A.E.; Vlase, L.; Benedec, D.; Hanganu, D.; Gheldiu, A.M.; Toma, V.A.l.; Oniga, I. Phytochemical profile, anti-738 oxidant, cardioprotective and nephroprotective activity of romanian chicory extract. Plants 2021, 10, 64. [Google Scholar] [CrossRef]
  57. Berker, K.; Guclu, K.; Tor, I.; Apak, R. Comparative evaluation of Fe (III) reducing power-based antioxidant capacity assays in the presence of phenanthroline, batho-phenanthroline, tripyridyltriazine (FRAP) and ferricyanide reagents. Talanta 2007, 72, 1157–1165. [Google Scholar] [CrossRef]
  58. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure–antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 1996, 20, 933–956. [Google Scholar] [CrossRef]
  59. Queiroz, D.P.K.; Ferreira, A.G.; Lima, A.S.; Lima, E.S.; Lima, M.P. Isolation and identification of α-glucosidase, α-amylase and lipase inhibitors from Hortia longifolia. Int. J. Pharm. Pharm. Sci. 2013, 5, 336–339. [Google Scholar]
  60. Ranilla, L.G.; Kwon, Y.I.; Apostolidis, E.; Shetty, K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101, 4676–4689. [Google Scholar] [CrossRef]
  61. Sahasrabudhe, A.; Deodhar, M. Anti-hyaluronidase, antielastase activity of Garcinia indica. Int. J. Bot. 2010, 6, 299–303. [Google Scholar] [CrossRef]
  62. Hamberg, M.; Samuelsson, B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J. Biol. Chem. 1967, 242, 5329–5335. [Google Scholar] [CrossRef]
  63. ISO 10993-5:2009; Biological Evaluation of Medical Devices Part 5: Tests for In Vitro Cytotoxicity. ISO: Genewa, Switzerland, 2009.
  64. Atkinson, I.; Seciu-Grama, A.M.; Serafim, A.; Petrescu, S.; Voicescu, M.; Anghel, E.M.; Marinescu, C.; Mitran, R.A.; Mocioiu, O.C.; Cusu, J.P.; et al. Bioinspired 3D scaffolds with antimicrobial, drug delivery, and osteogenic functions for bone regeneration. Drug Deliv. Transl. Res. 2024, 14, 1028–1047. [Google Scholar] [CrossRef]
  65. Moreira, S.A.; Pinto, C.A.; da Cruz Alexandre, E.M.; Pintado, M.E.; Saraiva, J.M. Assisted Extraction of Phenolic Compounds by Pressure-Based Technologies. In Technologies to Recover Polyphenols from AgroFood By-Products and Wastes; Academic Press: Cambridge, MA, USA, 2022; pp. 113–135. [Google Scholar]
  66. Becerra-Herrera, M.; Lazzoi, M.R.; Sayago, A.; Beltrán, R.; Del Sole, R.; Vasapollo, G. Extraction and determination of phenolic compounds in the berries of Sorbus americana Marsh and Lonicera oblongifolia (Goldie) Hook. Food Anal. Methods 2015, 8, 2554–2559. [Google Scholar] [CrossRef]
  67. Šavikin, K.P.; Zduni’c, G.M.; Krsti’c-Miloševi’c, D.B.; Šircelj, H.J.; Steševi’c, D.D. Sorbus aucuparia and Sorbus aria as a source of antioxidant phenolics, tocopherols, and pigments. Chem. Biodivers. 2017, 14, e1700329. [Google Scholar] [CrossRef]
  68. Arvinte, O.M.; Senila, L.; Becze, A.; Amariei, S. Rowanberry—A Source of Bioactive Compounds and Their Biopharmaceutical Properties. Plants 2023, 12, 3225. [Google Scholar] [CrossRef] [PubMed]
  69. Zhou, Y.; Jiang, Z.; Lu, H.; Xu, Z.; Tong, R.; Shi, J.; Jia, G. Recent advances of natural polyphenols activators for Keap1-Nrf2 signaling pathway. Chem. Biodivers. 2019, 16, e1900400. [Google Scholar] [CrossRef] [PubMed]
  70. Milenkovic, D.; Jude, B.; Morand, C. miRNA as molecular target of polyphenols underlying their biological effects. Free Radic. Biol. Med. 2013, 64, 40–51. [Google Scholar] [CrossRef]
  71. Perrone, P.; D’Angelo, S. Hormesis and health: Molecular mechanisms and the key role of polyphenols. Food Chem. Adv. 2025, 7, 101030. [Google Scholar] [CrossRef]
  72. Sarv, V.; Venskutonis, P.R.; Bhat, R. The Sorbus spp.—Underutilised Plants for Foods and Nutraceuticals: Review on Polyphenolic Phytochemicals and Antioxidant Potential. Antioxidants 2020, 9, 813. [Google Scholar] [CrossRef]
  73. Tian, Y.; Liimatainen, J.; Alanne, A.L.; Lindstedt, A.; Liu, P.; Sinkkonen, J.; Kallio, H.; Yang, B. Phenolic compounds extracted by acidic aqueous ethanol from berries and leaves of different berry plants. Food Chem. 2017, 220, 266–281. [Google Scholar] [CrossRef]
  74. Mikulic-Petkovsek, M.; Slatnar, A.; Stampar, F.; Veberic, R. HPLC–MSn identification and quantification of flavonol glycosides in 28 wild and cultivated berry species. Food Chem. 2012, 135, 2138. [Google Scholar] [CrossRef] [PubMed]
  75. Isaikina, N.V.; Kalinkina, G.I.; Razina, T.G.; Zueva, E.P.; Rybalkina, O.Y.; Ulirich, A.V.; Fedorova, E.P.; Shilova, A.B. Sorbus aucuparia L. Fruit Is a Source of the Drug for Increasing the Efficiency of Tumor Chemotherapy. Russ. J. Bioorg. Chem. 2018, 44, 899–905. [Google Scholar] [CrossRef]
  76. Hasbal, G.; Yilmaz-Ozden, T.; Can, A. Antioxidant and antiacetylcholinesterase activities of Sorbus torminalis (L.) Crantz (wild service tree) fruits. J. Food Drug Anal. 2015, 23, 57–62. [Google Scholar] [CrossRef] [PubMed]
  77. Fomenko, S.E.; Kushnerova, N.F.; Sprygin, V.G.; Drugova, E.S.; Momot, T.V. Chemical Composition and Biological Action of Rowanberry Extract. Russ. J. Bioorg. Chem. 2016, 42, 764–769. [Google Scholar] [CrossRef]
  78. Kähkönen, M.P.; Hopia, A.I.; Heinonen, M. Berry phenolics and their antioxidant activity. J. Agric. Food Chem. 2001, 49, 4076–4082. [Google Scholar] [CrossRef]
  79. Turumtay, H.; Midilli, A.; Turumtay, E.A.; Demir, A.; Selvi, E.K.; Budak, E.E.; Er, H.; Kocaimamoglu, F.; Baykal, H.; Belduz, A.O.; et al. Gram (-) microorganisms DNA polymerase inhibition, antibacterial and chemical properties of fruit and leaf extracts of Sorbus acuparia and Sorbus caucasica var. yaltirikii. Biomed. Chromatogr. 2017, 31, e3901. [Google Scholar] [CrossRef]
  80. Mlcek, J.; Rop, O.; Jurikova, T.; Sochor, J.; Fisera, M.; Balla, S.; Baron, M.; Hrabe, J. Bioactive compounds in sweet rowanberry fruits of interspecific rowan crosses. Cent. Eur. J. Biol. 2014, 9, 1078–1086. [Google Scholar] [CrossRef]
  81. Naveed, M.; Hejazic, V.; Abbasa, M.; Kambohd, A.A.; Khane, G.J.; Shumzaidf, M.; Ahmadg, F.; Babazadehh, D.; Fangi, F.X.; Modarresi-Ghazanij, F. Chlorogenic acid (CGA): A pharmacological review and call for further. BioMed. Pharmacother. 2018, 97, 67–74. [Google Scholar] [CrossRef]
  82. Forino, M.; Tenore, G.C.; Tartaglione, L.; Carmela, D.; Novellino, E.; Ciminiello, P. (1S,3R,4S,5R)5-O-Caffeoylquinic acid: Isolation, stereo-structure characterization and biological activity. Food Chem. 2015, 178, 306–310. [Google Scholar] [CrossRef]
  83. David, A.V.A.; Arulmoli, R.; Parasuraman, S. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn. Rev. 2016, 10, 84–89. [Google Scholar] [CrossRef] [PubMed]
  84. Ji, Y.; Li, X.; Wang, Z.; Xiao, W.; He, Z.; Xiong, Z.; Zhao, L. Extraction optimization of accelerated solvent extraction for eight active compounds from Yaobitong capsule using response surface methodology: Comparison with ultrasonic and reflux extraction. J. Chromatogr. A 2020, 1620, 460984. [Google Scholar] [CrossRef]
  85. Culas, M.S.; Kaur, L.; Popovich, D.G.; Rashidinejad, A. Comparative efficiency of extraction techniques for bioactive compounds in Cinnamomum zeylanicum. Food Chem. 2025, 493, 145891. [Google Scholar] [CrossRef] [PubMed]
  86. Boath, A.S.; Stewart, D.; McDougall, G.J. Berry components inhibit α-glucosidase in vitro: Synergies between acarbose and polyphenols from black currant and rowanberry. Food Chem. 2012, 135, 929–936. [Google Scholar] [CrossRef] [PubMed]
  87. Wei, J.; Zhang, G.; Zhang, X.; Gao, J.; Zhou, Z.; Fan, J. Polyphenols from Sorbus aucuparia ameliorate insulin resistance and metabolic disorders in diabetic mice. Curr. Top. Nutraceutical Res. 2016, 14, 227–233. [Google Scholar]
  88. Rutkowska, M.; Kolodziejczyk-Czepas, J.; Owczarek, A.; Zakrzewska, A.; Magiera, A.; Olszewska, M.A. Novel insight into biological activity and phytochemical composition of Sorbus aucuparia L. fruits: Fractionated extracts as inhibitors of protein glycation and oxidative/nitrative damage of human plasma components. Food Res. Int. 2021, 147, 110526. [Google Scholar] [CrossRef]
  89. Chandran, A.K.; Stach, M.; Kucharska, A.Z.; Sokół-Łętowska, A.; Szumny, A.; Moreira, H.; Szyjka, A.; Barg, E.; Kolniak-Ostek, J. Comparison of polyphenol and volatile compounds and in vitro antioxidant, anti-inflammatory, antidiabetic, anti-ageing, and anticancer activities of dry tea leaves. LWT 2025, 222, 117632. [Google Scholar] [CrossRef]
  90. Abid, A.; Wafa, Z.; Belguidoum, M.; Touahria, T.; Mekhadmi, N.E.; Dekmouche, M.; Bechki, L.; Bireche, K.; Boussebaa, W.; Al-Farga, A. Exploring the anti-inflammatory, sedative, antidiabetic, and antioxidant potential in in-vitro and in-vivo models and phenolic profiling of Atractylis aristata Batt. J. Ethnopharmacol. 2024, 330, 118252. [Google Scholar] [CrossRef]
  91. Owczarek, K.; Lewandowska, U. The impact of dietary polyphenols on COX-2 expression in colorectal cancer. Nutr. Cancer 2017, 69, 1105–1118. [Google Scholar] [CrossRef]
  92. Huang, J.; Xie, M.; He, L.; Song, X.; Cao, T. Chlorogenic acid: A review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems. Front. Pharmacol. 2023, 14, 1218015. [Google Scholar] [CrossRef]
  93. Rutkowska, M.; Owczarek, A.; Kolodziejczyk-Czepas, J.; Michel, P.; Piotrowska, D.G.; Kapusta, P.; Nowak, P.; Olszewska, M.A. Identification of bioactivity markers of Sorbus domestica leaves in chromatographic, spectroscopic and biological capacity tests: Application for the quality control. Phytochem. Lett. 2019, 30, 278–287. [Google Scholar] [CrossRef]
  94. Olszewska, M.A.; Kolodziejczyk-Czepas, J.; Rutkowska, M.; Magiera, A.; Michel, P.; Rejman, M.W.; Nowak, P.; Owczarek, A. The effect of standardised flower extracts of Sorbus aucuparia L. on proinflammatory enzymes, multiple oxidants, and oxidative/nitrative damage of human plasma components in vitro. Oxidative Med. Cell. Longev. 2019, 2019, 9746358. [Google Scholar] [CrossRef] [PubMed]
  95. Yu, T.; Lee, Y.J.; Jang, H.J.; Kim, A.R.; Hong, S.; Kim, T.W.; Kim, M.Y.; Lee, J.; Lee, Y.G.; Cho, J.Y. Anti-inflammatory activity of Sorbus commixta water extract and its molecular inhibitory mechanism. J. Ethnopharmacol. 2011, 134, 493–500. [Google Scholar] [CrossRef] [PubMed]
  96. Yang, G.; An, H.-J. β-sitosteryl-3-O-β-glucopyranoside isolated from the bark of Sorbus commixta ameliorates proinflammatory mediators in RAW 264.7 macrophages. Immunopharmacol. Immunotoxicol. 2014, 36, 70–77. [Google Scholar] [CrossRef] [PubMed]
  97. Kazmi, M.H.; Ahmed, E.; Hameed, S.; Malik, A.; Fatima, I.; Ashraf, M. (Cashmirols A and B, new Lipoxygenase Inhibiting Triterpenes from Sorbus cashmiriana. Chem. Biodivers. 2009, 6, 1471–1476. [Google Scholar] [CrossRef]
  98. Raspé, O.; Findlay, C.; Jacquemart, A.L. Sorbus aucuparia L. J. Ecol. 2000, 88, 910–930. [Google Scholar] [CrossRef]
Figure 1. HPLC-MS chromatograms obtained for S. aucuparia extract (1-chlorogenic acid, [M-H]− 353; 2-quercetin 3-β-D-glucoside, [M-H]− 463; 3-4-hydroxybenzoic acid, [M-H]− 137; 4-caffeic acid, [M-H]− 179; 5-epicatchin, [M-H]− 289; 6-p-coumaric acid, [M-H]− 163; 7-rutin, [M-H]− 609; 8-ellagic acid, [M-H]− 301; 9-quercitrin, [M-H]− 447; 10-luteolin, [M-H]− 285; 11-quercetin, [M-H]− 301; 12-kaempferol, [M-H]− 285) by HPLC-MS.
Figure 1. HPLC-MS chromatograms obtained for S. aucuparia extract (1-chlorogenic acid, [M-H]− 353; 2-quercetin 3-β-D-glucoside, [M-H]− 463; 3-4-hydroxybenzoic acid, [M-H]− 137; 4-caffeic acid, [M-H]− 179; 5-epicatchin, [M-H]− 289; 6-p-coumaric acid, [M-H]− 163; 7-rutin, [M-H]− 609; 8-ellagic acid, [M-H]− 301; 9-quercitrin, [M-H]− 447; 10-luteolin, [M-H]− 285; 11-quercetin, [M-H]− 301; 12-kaempferol, [M-H]− 285) by HPLC-MS.
Applsci 15 12585 g001
Figure 2. Cell viability of L929 cells after 24 and 48 h of incubation with ASE (A) and UAE (B) extracts at different concentrations, as determined by the MTT assay. UAE_MF = microfiltrate extract obtained by ultrasound-assisted extraction; UAE_C = concentrate extract obtained by ultrasound-assisted extraction; ASE_MF = microfiltrate extract obtained by accelerated solvent extraction; ASE_C = concentrate extract obtained by accelerated solvent extraction; data were expressed as the average of three replicates (mean ± SD). * p < 0.05, # p <0.01.
Figure 2. Cell viability of L929 cells after 24 and 48 h of incubation with ASE (A) and UAE (B) extracts at different concentrations, as determined by the MTT assay. UAE_MF = microfiltrate extract obtained by ultrasound-assisted extraction; UAE_C = concentrate extract obtained by ultrasound-assisted extraction; ASE_MF = microfiltrate extract obtained by accelerated solvent extraction; ASE_C = concentrate extract obtained by accelerated solvent extraction; data were expressed as the average of three replicates (mean ± SD). * p < 0.05, # p <0.01.
Applsci 15 12585 g002
Table 1. The content of biologically active compounds (total polyphenols, flavonoids) and the extraction yield of extracts from S. aucuparia fruits results.
Table 1. The content of biologically active compounds (total polyphenols, flavonoids) and the extraction yield of extracts from S. aucuparia fruits results.
SamplesExtraction MethodTotal Polyphenols
Concentration ± SD (CA μg/mL)
Flavonoids
Concentration ± SD (RU μg/mL)
Yield (%)
S. aucuparia
fruit extracts
ASEMicrofiltrate2265.62 ± 52.63377.88 ± 17.3214.09
Concentrate2692.53 ± 37.89433.88 ± 21.1229.06
UAEMicrofiltrate1246.85 ± 28.39191.12 ± 5.2313.13
Concentrate1576.24 ± 32.78230.88 ± 10.3222.12
SD = standard deviation; CA = chlorogenic acid equivalent; RU = rutin equivalent; ASE = accelerated solvent extraction; UAE = ultrasound-assisted extraction. ANOVA results: the differences in the mean values among the treatment groups are not great enough to exclude the possibility that the difference is due to random sampling variability; there was no statistically significant difference (p = 0.275).
Table 2. HPLC-MS analysis of the polyphenolic profile for extracts from the S. aucuparia fruit results.
Table 2. HPLC-MS analysis of the polyphenolic profile for extracts from the S. aucuparia fruit results.
CompoundExtract ASEExtract UAE
Microfiltrate Conc ± SD μg/mLConcentrate
Conc ± SD μg/mL
Microfiltrate Conc ± SD
μg/mL
Concentrate
Conc ± SD
μg/mL
Coumaric acid0.39 ± 0.010.45 ± 0.210.22 ± 0.010.26 ± 0.01
Gallic acid----
Caffeic acid32.67 ± 0.1234.41 ± 1.2116.40 ± 0.7316.27 ± 1.12
Luteolin0.04 ± 0.010.04 ± 0.0010.02 ± 0.0010.02 ± 0.001
Kaempferol0.13 ± 0.010.14 ± 0.0010.09 ± 0.0040.10 ± 0.001
Ellagic acid1.59 ± 0.023.81 ± 0.020.92 ± 0.042.20 ± 0.12
Quercetin1.45 ± 0.011.66 ± 0.011.33 ± 0.011.28 ± 0.01
p-hydroxybenzoic acid14.71 ± 0.8915.09 ± 0.896.93 ± 0.038.81 ± 0.28
Myricetin----
Chlorogenic acid473.54 ± 20.12526.08 ± 23.35273.98 ± 10.81296.80 ± 12.35
Quercitrin2.52 ± 0.133.81 ± 0.141.34 ± 0.011.46 ± 0.01
Quercetin 3-β-D-glucoside15.82 ± 0.8917.27 ± 0.5621.28 ± 1.2923.37 ± 1.12
Rutin13.68 ± 0.7836.07 ± 1.234.85 ± 0.146.31 ± 0. 23
Epicatechin4.65 ± 0.234.75 ± 0.121.15 ± 0.011.92 ± 0.02
SD = standard deviation; ASE = accelerated solvent extraction; UAE = ultrasound-assisted extraction, ANOVA results: there is a statistically significant difference (p < 0.001).
Table 3. The antioxidant activity of the extracts.
Table 3. The antioxidant activity of the extracts.
SamplesDPPH Radical Scavenging Activity
IC50 (µg/mL)
Reducing Power Activity
IC50 (µg/mL)
TEACABTS
(μmolTrolox/g)
ASEUAEASEUAEASEUAE
S. aucuparia fruit extractsMicrofiltrate43.57 ± 1.62 *54.98 ± 2.15 *52.14 ± 2.62 *75.74 ± 3.25 *41.90 ± 2.97 *22.61 ± 0.90
Concentrate39.07 ± 0.32 *50.98 ± 1.1 *47.36 ± 1.65 *49.61 ± 1.2 *50.81 ± 2.87 *32.33 ± 1.10 *
Vitamin C 46.47 ± 1.3836.32 ± 1.2568.61 ± 2.32
The data represent the average of experiments performed in triplicate; * p < 0.05, the reducing power compared with the polyphenol and flavonoid content of the extracts by Student’s t-test; * p < 0.05, the radical scavenging activity compared with the polyphenol and flavonoid content of the extracts by Student’s t-test.
Table 4. α-amylase and α-glucosidase inhibition activity by analyzed extracts.
Table 4. α-amylase and α-glucosidase inhibition activity by analyzed extracts.
Samplesα-Amylase Inhibition
IC50 (µg/mL)
α-Glucosidase Inhibition
IC50 (µg/mL)
ASEUAEASEUAE
S. aucuparia extractsMicrofiltrate32.87 ± 2.15 *48.38 ± 3.56 *15.26 ± 0.98 *25.21 ± 1.36 *
Concentrate23.74 ± 1.32 *38.23 ± 2.53 *13.50 ± 0.96 *21.53 ± 1.25 *
Acarbose 22.65 ± 1.2720.19 ± 1.67
Values are in form mean ± standard deviation (n = 3); statistical significance (* p < 0.05) is obtained for both enzymes’ inhibition linked with studied compounds content in extracts.
Table 5. Lipoxygenase and hyaluronidase inhibition activity of the analyzed extracts.
Table 5. Lipoxygenase and hyaluronidase inhibition activity of the analyzed extracts.
SamplesLipoxygenase Inhibition
IC50 (µg/mL)
Hyaluronidase Inhibition
IC50 (µg/mL)
ASEUAEASEUAE
S. aucuparia extractsMicrofiltrate40.11 ± 2.21 *73.63 ± 4.35 *70.67 ± 2.53 *65.82 ± 3.16 *
Concentrate24.30 ± 1.54 *31.01 ± 2.36 *43.04 ± 2.19 *48.49 ± 3.15 *
Ibuprofen 26.91 ± 1.2751.54 ± 3.67
Values are in form mean ± standard deviation (n = 3); statistical significance (* p < 0.05) is obtained for both enzymes’ inhibition linked with studied compounds content in extracts.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Neagu, E.; Paun, G.; Albu, C.; Badea, G.; Seciu-Grama, A.M.; Radu, G.L. Antidiabetic and Anti-Inflammatory Potential of Sorbus aucuparia Fruits (Rowanberries) from Romania. Appl. Sci. 2025, 15, 12585. https://doi.org/10.3390/app152312585

AMA Style

Neagu E, Paun G, Albu C, Badea G, Seciu-Grama AM, Radu GL. Antidiabetic and Anti-Inflammatory Potential of Sorbus aucuparia Fruits (Rowanberries) from Romania. Applied Sciences. 2025; 15(23):12585. https://doi.org/10.3390/app152312585

Chicago/Turabian Style

Neagu, Elena, Gabriela Paun, Camelia Albu, Georgiana Badea, Ana Maria Seciu-Grama, and Gabriel Lucian Radu. 2025. "Antidiabetic and Anti-Inflammatory Potential of Sorbus aucuparia Fruits (Rowanberries) from Romania" Applied Sciences 15, no. 23: 12585. https://doi.org/10.3390/app152312585

APA Style

Neagu, E., Paun, G., Albu, C., Badea, G., Seciu-Grama, A. M., & Radu, G. L. (2025). Antidiabetic and Anti-Inflammatory Potential of Sorbus aucuparia Fruits (Rowanberries) from Romania. Applied Sciences, 15(23), 12585. https://doi.org/10.3390/app152312585

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop